The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes of patients with advanced non-small cell lung cancer and driver mutations treated with frontline immunotherapy and/or chemotherapy.
 
Bharathi Muthusamy
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cota Healthcare; G1 Therapeutics; Genentech; Inivata; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer; Viosera Therapeutics; Xencor
Research Funding - Altor BioScience (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Heat Biologics (Inst); Jounce Therapeutics (Inst); Loxo (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Spectrum Pharmaceuticals (Inst); WindMIL (Inst)
 
Andrew J. Belli
Employment - COTA
Stock and Other Ownership Interests - COTA
 
Eric Hansen
Employment - COTA Healthcare
Stock and Other Ownership Interests - Abbvie; COTA Healthcare; Johnson & Johnson; UnitedHealthcare
 
Victoria Devincenzo
No Relationships to Disclose
 
Shubha Shankaranarayana
Employment - Optum
 
Ming He
No Relationships to Disclose
 
Ching-Kun Wang
Employment - COTA
Leadership - COTA
Stock and Other Ownership Interests - COTA
Honoraria - PierianDx